<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260701070041N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-14</date_registration>
      <primary_sponsor>Kharazmi University</primary_sponsor>
      <public_title>Effects of Adding Perturbation Exercises to Scapular Stabilization Training on Scapula Two-Dimensional Kinematics, Proprioception, Strength, and Endurance, and Function of Upper extremity, in Overhead Athletes with Fatigue-Induced Scapular Dyskinesis</public_title>
      <acronym></acronym>
      <scientific_title>Effects of Adding Perturbation Exercises to Scapular Stabilization Training on Scapula Two-Dimensional Kinematics, Proprioception, Strength, and Endurance, and Function of Upper extremity, in Overhead Athletes with Fatigue-Induced Scapular Dyskinesis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-10-17</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>48</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/91424</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Stratified randomization by sport, using random blocks and a 1:1:1 allocation ratio within each stratum, will be performed. The allocation sequence will be generated using a computerized random sequence generation tool (Random.org). Allocation concealment will be ensured using sequentially numbered, opaque, sealed envelopes. Group allocation will be performed after completion of the baseline assessments, Blinding description: This study will be conducted using a single-blind design. The outcome assessor will be blinded to participants’ group allocation during both baseline and post-intervention assessments. The data analyst will also perform the statistical analyses using group codes A, B, and C without knowledge of the nature of the groups, and the group codes will be revealed after completion of the statistical analyses. Due to the nature of the interventions, participants and intervention providers will be aware of their group allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Scapular Dyskinesis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention  Group 1 (SST): Participants in this group will participate in a structured scapular stabilization training program for 8 weeks, with three supervised sessions per week. Each 60-minute session will consist of 10 minutes of warm-up, 45 minutes of main exercise, and 5 minutes of cool-down. During the first 30 minutes of the main exercise period, participants will perform the standardized scapular stabilization training program. The final 15 minutes will consist of an active non-perturbation program matched for time and therapist attention. Exercise intensity will be prescribed using the RPE scale and progressively adjusted based on maintenance of movement quality and scapular control. Intervention 2: Intervention  Group 2 (SST+PT): Participants in this group will participate in a structured scapular stabilization training program combined with perturbation training for 8 weeks, with three supervised sessions per week. Each 60-minute session will consist of 10 minutes of warm-up, 45 minutes of main exercise, and 5 minutes of cool-down. During the first 30 minutes of the main exercise period, participants will perform the same standardized scapular stabilization training program as the SST group. The final 15 minutes will consist of a specific program incorporating dynamic stabilization and perturbation exercises. This component will progress in stages over the 8-week intervention. Exercise intensity will be prescribed using the RPE scale and progressively adjusted based on maintenance of movement quality and scapular control. Intervention 3: Control  group: Group 3: No exercise intervention (usual upper extremity activity group). Group 3 will not receive any structured exercise program during the 8-week study period and will continue their usual daily and sporting activities. No specific scapular Stabilization or perturbation exercises will be provided. The control group is included for comparison with the intervention groups.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No further information is available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Pejman Enayatzadeh Gerayli</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Center for Human Movement Sciences, Kharazmi University, Hesari St, Mirdamad St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1571914911</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>pejmann.enayatzadeh79@gmail.com</email>
        <affiliation>The University of Kharazmi</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Malihe Hadadnezhad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Center for Human Movement Sciences, Kharazmi University, Hesari St, Mirdamad St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1571914911</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>m.hadadnezhad@yahoo.com</email>
        <affiliation>The University of Kharazmi</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>-Participants must demonstrate a normal scapular pattern at rest and exhibit scapular dyskinesis following a standardized fatigue protocol, as assessed by the Kibler test.
-Participants must be actively engaged in overhead sports for at least 4 hours per week.
-Age of participants must be between 20 and 40 years.
-Body mass index (BMI) must be between 18.5 and 25 kg/m².</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1.	History of shoulder pain within the past year.
2.	Capsular shoulder stiffness (adhesive capsulitis).
3.	Previous shoulder surgery within the past year.
4.	History of shoulder fracture.
5.	Systemic musculoskeletal diseases (e.g., rheumatoid arthritis, fibromyalgia, etc.).
6.	Shoulder pain reproduced by active or passive cervical spine movements.
7.	History of rotator cuff or labral tears.
8.	Shoulder dislocation within the past year.
9.	Current or previous glenohumeral instability.
10.	Clavicle or humerus fracture.
11.	Cervical radiculopathy.
12.	Spinal deformities such as scoliosis.
13.	Thoracic kyphosis outside normal range.
14.	Cervical hyperlordosis.
15.	Lower limb length discrepancy.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M99.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Biomechanical lesion, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention  Group 1 (SST): Participants in this group will participate in a structured scapular stabilization training program for 8 weeks, with three supervised sessions per week. Each 60-minute session will consist of 10 minutes of warm-up, 45 minutes of main exercise, and 5 minutes of cool-down. During the first 30 minutes of the main exercise period, participants will perform the standardized scapular stabilization training program. The final 15 minutes will consist of an active non-perturbation program matched for time and therapist attention. Exercise intensity will be prescribed using the RPE scale and progressively adjusted based on maintenance of movement quality and scapular control.</i_keyword>
      <i_keyword>Intervention  Group 2 (SST+PT): Participants in this group will participate in a structured scapular stabilization training program combined with perturbation training for 8 weeks, with three supervised sessions per week. Each 60-minute session will consist of 10 minutes of warm-up, 45 minutes of main exercise, and 5 minutes of cool-down. During the first 30 minutes of the main exercise period, participants will perform the same standardized scapular stabilization training program as the SST group. The final 15 minutes will consist of a specific program incorporating dynamic stabilization and perturbation exercises. This component will progress in stages over the 8-week intervention. Exercise intensity will be prescribed using the RPE scale and progressively adjusted based on maintenance of movement quality and scapular control.</i_keyword>
      <i_keyword>Control  group: Group 3: No exercise intervention (usual upper extremity activity group). Group 3 will not receive any structured exercise program during the 8-week study period and will continue their usual daily and sporting activities. No specific scapular Stabilization or perturbation exercises will be provided. The control group is included for comparison with the intervention groups.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Two-dimensional scapular upward rotation. Timepoint: Baseline (T0), post-intervention (T1, 8 weeks; at least 48 hours after the last training session). Method of measurement: Scapular  two-dimensional kinematics will be assessed using two calibrated gravity-based inclinometers. One inclinometer (I1) will be attached to the distal humerus to record total shoulder abduction, and the second inclinometer (I2) will be placed on the scapular spine to assess scapular upward rotation. Measurements will be taken at 45°, 90°, 135°, and at the end range of shoulder abduction. Each measurement will be repeated twice within the same session.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Shoulder proprioception. Timepoint: Baseline (T0), post-intervention (T1, 8 weeks; at least 48 hours after the last training session). Method of measurement: Proprioception  will be assessed using the joint position sense (JPS) test. Participants will lie supine with the shoulder abducted to 90° and the elbow flexed to 90°. A blindfold will be used to eliminate visual input. The examiner will passively move the shoulder to target angles of 45° and 80° of external rotation and hold each position for 5 seconds. Participants will then actively reproduce the target angle. Absolute error (degrees) between the target and reproduced angles will be calculated as the outcome measure.A digital camera positioned at 10 meters will be used for recording, and angles will be calculated using Kineova software. Anatomical reference lines include the horizontal line of the plinth and the line from the olecranon to the ulnar styloid process.</sec_outcome>
      <sec_outcome>Upper extermity function. Timepoint: Baseline (T0), post-intervention (T1, 8 weeks; at least 48 hours after the last training session). Method of measurement: The Closed  Kinetic Chain Upper Extremity Stability Test (CKCUEST) will be performed using two parallel tape lines placed 91.44 cm (36 inches) apart. Participants will assume a push-up position with each hand placed on a separate line. The test duration is 15 seconds, during which participants will alternately touch the opposite line as many times as possible. One familiarization trial (submaximal effort) will be performed followed by three maximal trials. A 45-second rest period will be provided between trials (work-to-rest ratio 1:3). The mean of the three trials will be used for statistical analysis.</sec_outcome>
      <sec_outcome>Shoulder rotator strength. Timepoint: Baseline (T0), post-intervention (T1, 8 weeks; at least 48 hours after the last training session). Method of measurement: Shoulder  rotator muscle strength will be assessed using a handheld dynamometer. Measurements will be performed in three positions: seated with 0° adduction (neutral), prone with 90° abduction, and seated with 30° abduction + 30° scaption + 30° diagonal position. The elbow will be flexed to 90° during all tests. The make contraction method will be used, where participants gradually reach maximal force over 2 seconds and maintain it for 5 seconds. If the participant is unable to maintain force, the trial will be repeated. Force will be applied 1.3 cm proximal to the ulnar styloid process. Maximal isometric force will be recorded in Newtons (N), and the external rotation to internal rotation (ER/IR) strength ratio will be calculated. The order of positions, limb tested, and movement type will be randomized.</sec_outcome>
      <sec_outcome>Scapular muscle endurance. Timepoint: Baseline (T0), post-intervention (T1, 8 weeks; at least 48 hours after the last training session). Method of measurement: Scapular  muscle endurance will be assessed in a standing position facing a wall. The shoulder and elbow will be positioned at 90° flexion. A dynamometer will be placed between the hands, and a distance gauge will be used to control elbow position. Participants will maintain a resistance of 1 kg during external rotation and hold the position until fatigue. The test will be terminated when the participant is unable to maintain the target resistance, when elbow position deviates from the required distance, or when the 90° joint angle is lost.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>This study was conducted by the researchers and did not receive any organizational funding.</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-06-17</approval_date>
        <contact_name>Ethics Committee of Kharazmi University</contact_name>
        <contact_address>Center for Human Movement Sciences, Kharazmi University, Hesari St, Mirdamad St. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
